 |
 |
 |
Best Fat Paysites
|
| fatty post , icp, coconut fatty acid , wilson disease, plump dj's , liver pregnancy, plump black , perimenopause, pleasingly plump , lyrics to bounce by fatty koo , plump ebony , hrt, plump rumps tgp , fever, | Pregnancy Outcome* Probability Reference Values Risk Assessment Severity of Illness Index Substances: Fatty Acids PMID: 16394048 [PubMed - indexed for MEDLINE] Display Summary Brief Abstract Citation MEDLINE oncology XML UI List LinkOut ASN.1 Related Articles Cited Articles Cited in Books CancerChrom Links Domain Links 3D Domain Links GEO DataSet Links Gene Links Gene (GeneRIF) Links Genome Links Project Links GENSAT Links GEO Profile Links HomoloGene oncology Links Nucleotide Links OMIA Links OMIM (calculated) Links OMIM (cited) Links BioAssay Links Compound Links Compound via MeSH oncology Substance Links Substance via MeSH PMC Links Cited in PMC PopSet Links Probe Links Protein Links SNP Links Structure Links UniGene Links UniSTS Links Show 5 10 20 50 100 200 500 Sort by Pub Date First Author Last Author Journal Send to Text File Printer Clipboard E-mail Order Write to the Help Desk NCBI | NLM | NIH Department of Health & Human Services Privacy Statement | Freedom of Information Act | Disclaimer Mar 13 2006 06:33:20 bgcolor="#336699" align="left">My NCBI[Sign In] [Register] All Databases |
|
| Long chain defects were 50 times more likely than controls to develop maternal liver disease and short and medium chain defects were 12 times more likely to develop maternal liver disease. CONCLUSION: Maternal liver disease is significantly higher across the entire spectrum of fatty acid oxidation defects pregnancies compared with the matched control population. Notably, there is significant risk to the pregnancies with fetuses affected with fatty post short and medium chain defects, not fatty post just those with fetal long chain fatty acid oxidation defects as previously reported. Future studies should examine the pathophysiology of all fatty post infant fatty acid oxidation defects and its implications for maternal liver disease for improved future health outcomes. LEVEL OF EVIDENCE: II-2.MeSH Terms: Case-Control Studies Comparative Study Confidence Intervals Fatty Acids/metabolism Fatty Liver/diagnosis* Fatty Liver/epidemiology Female Fetal Diseases/diagnosis* Fetal Diseases/epidemiology Follow-Up Studies Gestational Age HELLP Syndrome/diagnosis HELLP Syndrome/epidemiology Humans Infant, Newborn Maternal Age Maternal-Fetal Exchange Metabolism, Inborn Errors/diagnosis* Metabolism, Inborn Errors/epidemiology Odds Ratio Pregnancy Pregnancy Complications/diagnosis* Pregnancy Complications/epidemiology |
|
Looking for real sex? Find someone now on the
largest sex personals network.FREE signup! Post a FREE erotic ad w/5 photos, flirt in chatrooms, view explicit live Webcams, meet for REAL sex! 30,000 new photos every day! Find SEX now 
|
